Gastrointestinal Bleeding Treatment Market – By Product (Endoscopic Hemostatic Devices [Mechanical, Thermal], Closure Devices), GI Tract Division (Upper, Lower), Onset (Acute, Chronic), End-use (Hospitals, ASCs) - Global Forecast (2024 – 2032)

Gastrointestinal Bleeding Treatment Market – By Product (Endoscopic Hemostatic Devices [Mechanical, Thermal], Closure Devices), GI Tract Division (Upper, Lower), Onset (Acute, Chronic), End-use (Hospitals, ASCs) - Global Forecast (2024 – 2032)

Global Gastrointestinal Bleeding Treatment Market size will record 7.9% CAGR between 2024 and 2032, propelled by technological advancements in endoscopic procedures and medical devices, along with the establishment of specialized centers. Enhanced endoscopic tools offer more precise and minimally invasive interventions for improving patient outcomes. The rise of specialized centers is helping to cater to the specific needs of patients, further increasing access to advanced treatments. This enhances treatment efficacy for shaping a more comprehensive and efficient healthcare landscape. For instance, in September 2023, Apollo Hospitals inaugurated a specialized center for providing comprehensive care and advanced treatments for patients suffering from gastrointestinal bleeding.

The gastrointestinal bleeding treatment industry is fragmented into product, end-use, onset, GI tract division, and region.

By product, the market size from the closure devices segment will achieve a considerable share by 2032, fueled by the demand for minimally invasive solutions. These devices, including hemostatic clips and suturing devices, offer effective and less invasive alternatives to traditional surgical methods. With the increasing adoption of endoscopic procedures, closure devices provide efficient hemostasis and prevent re-bleeding. Moreover, benefits like ease of use and reduced hospital stay are contributing to their popularity among clinicians and patients.

Based on end-use, gastrointestinal bleeding treatment market from the ambulatory surgical centers (ASCs) segment will experience a substantial upswing by 2032, attributed to the increasing preference for outpatient procedures due to their cost-effectiveness and convenience. ASCs offer a range of endoscopic procedures for gastrointestinal bleeding for providing efficient and timely interventions. With advancements in technology and skilled healthcare professionals in ASCs, patients can receive prompt and specialized care. The shift towards outpatient settings for gastrointestinal treatments for offering a compelling option for both patients and healthcare providers will add to the segment growth.

Asia Pacific gastrointestinal bleeding treatment market will exhibit a noteworthy CAGR from 2024 to 2032, fueled by the high prevalence of gastrointestinal disorders in the region and the growing aging population. Increased healthcare spending and advancements in medical infrastructure will further contribute to this trend. With rising focus on early detection and effective treatment, Asia Pacific will stand out as a key contributor to the industry.